At Quantum Pharma we provide the following products and services to our clients.
Whether it be taking a patient-ready product through the validation process for first in human clinical research use; translating a product from pre-human to human use; or developing production and analytical methods, our radiochemistry team work closely with stakeholders to achieve desired outcomes. Our knowledge of the Australian market and clinical sites can help connect development companies with clinics and clinicians with optimal patient populations. Our team is at the forefront of medical trends in drug development involving radiopharmaceuticals.
We work with stakeholders to take novel concepts and ideas from pre-clinical to clinical, supporting first in human trials, optimising labelling processes, analytical techniques and clinical production capabilities.
Members of our team have been at the forefront of Theranostics since it’s reinvigoration in the early 2000’s, right through to today’s cutting-edge alpha and beta peptide, small molecule and antibody radionuclide therapies.
We support leading radiopharmaceutical research by facilitating access to clinical trial participation. With our highly experienced clinical team we are able to assist in early phase clinical trials.
Our team has varied backgrounds including Radiopharmacy, Radiochemistry and Nuclear Medicine/PET. The diverse, highly experienced clinical and research expertise within our team is well situated to provide support. We work with hospitals, clinics and doctors from various health organisations, pharma companies and radionuclide suppliers.
We currently have transportation networks and partners that support the delivery of products across Melbourne, Sydney and throughout the rest of Australia. We also partner with local importers sourcing products from varied international suppliers.
Robinson Road Post Office, P.O. Box 1941, Singapore 903841
Tel: +65 6407 6346
Monday - Friday: 9am - 5pm Saturday - Sunday: Closed
642 Doncaster Road, Unit 615, Doncaster Victoria 3108, Australia
Tel: +61 431 863 651
Monday - Friday: 9am - 5pm Saturday - Sunday: Closed
SRS Leadership is looking forward to welcoming you to the Gold Coast in Queensland, Australia for the 26th International Symposium on Radiopharmaceutical Sciences May 11 to May 15, 2025
55th ANZSNM Annual Scientific Meeting. 23rd - 25th May 2025 in Melbourne.
MSAC released a Public Summary Document regarding the Application No 1686.1 - 177Lutetium PSMA i&t for metastatic castrate resistant prostate cancer regarding advice to the minister that it supports the creation of an MBS item descriptor agnostic tot he type of 177Lu PSMA therapy.